Literature DB >> 27021023

Genetic Variants of Microtubule Actin Cross-linking Factor 1 (MACF1) Confer Risk for Parkinson's Disease.

Xin Wang1,2,3, Nuomin Li4,5,6, Nian Xiong4,7,5,8,9, Qi You4,5,10, Jie Li4,11, Jinlong Yu4, Hong Qing6, Tao Wang9, Heather J Cordell12, Ole Isacson7,8,13, Jeffery M Vance14, Eden R Martin14, Ying Zhao4,5,15, Bruce M Cohen4,7, Edgar A Buttner4,7, Zhicheng Lin16,17,18,19.   

Abstract

The cytoskeleton not only provides structure, it is an active component of cell function, and in several neurodegenerative disorders, there is evidence of cytoskeletal collapse. Cytoskeletal proteins have been specifically implicated in the pathogenesis of Parkinson's disease (PD), where degeneration of dopaminergic (DA) neurons is the hallmark, but in which many factors may determine the resilience of DA neurons during aging and stress. Here we report that the human Microtubule Actin Cross-linking Factor 1 gene (MACF1), a downstream target of PD biochemical pathways, was significantly associated with PD in 713 nuclear families. A significant allelic association between PD and rs12118033, with P = 0.0098, was observed, and a P < 0.03 was observed in the association analysis by both a trend test and an allelic test. We further observed that it is the MACF1b isoform, not the MACF1a isoform, which is expressed in DA neurons from six human postmortem brains. In a Caenorhabditis elegans system, used to explore the effect of altered MACF1b on neurons, knockdown or knockout of the MACF1b orthologue vab-10 resulted in the selective loss of DA neurons, which validated MACF1's risk candidacy in PD. These findings strongly suggest that MACF1b may contribute to the genetic etiology and mechanistic causation of PD.

Entities:  

Keywords:  Association study; Caenorhabditis elegans modeling; Genetics; Nuclear family study; Parkinson’s disease

Mesh:

Substances:

Year:  2016        PMID: 27021023     DOI: 10.1007/s12035-016-9861-y

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  71 in total

1.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Authors:  Chee Yeun Chung; Hyemyung Seo; Kai Christian Sonntag; Andrew Brooks; Ling Lin; Ole Isacson
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

2.  beta-Thalassemia mutation at -90C-->T impairs the interaction of the proximal CACCC box with both erythroid and nonerythroid factors.

Authors:  P Faustino; J Lavinha; M G Marini; P Moi
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

3.  A Candidate-Pathway Approach to Identify Gene-Environment Interactions: Analyses of Colon Cancer Risk and Survival.

Authors:  Noha Sharafeldin; Martha L Slattery; Qi Liu; Conrado Franco-Villalobos; Bette J Caan; John D Potter; Yutaka Yasui
Journal:  J Natl Cancer Inst       Date:  2015-06-13       Impact factor: 13.506

Review 4.  Advances in the genetics of Parkinson disease.

Authors:  Joanne Trinh; Matt Farrer
Journal:  Nat Rev Neurol       Date:  2013-07-16       Impact factor: 42.937

5.  Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings.

Authors:  Evelyn Braungart; Manfred Gerlach; Peter Riederer; Ralf Baumeister; Marius C Hoener
Journal:  Neurodegener Dis       Date:  2004       Impact factor: 2.977

6.  Occurrence of Parkinson's syndrome in type I Gaucher disease.

Authors:  O Neudorfer; N Giladi; D Elstein; A Abrahamov; T Turezkite; E Aghai; A Reches; B Bembi; A Zimran
Journal:  QJM       Date:  1996-09

7.  Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease.

Authors:  Sofia A Oliveira; Yi-Ju Li; Maher A Noureddine; Stephan Zuchner; Xuejun Qin; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Am J Hum Genet       Date:  2005-06-28       Impact factor: 11.025

8.  Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach.

Authors:  Yvonne J K Edwards; Gary W Beecham; William K Scott; Sawsan Khuri; Guney Bademci; Demet Tekin; Eden R Martin; Zhijie Jiang; Deborah C Mash; Jarlath ffrench-Mullen; Margaret A Pericak-Vance; Nicholas Tsinoremas; Jeffery M Vance
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

9.  Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular era.

Authors:  Richard Kim; Michael J Schell; Jamie K Teer; Danielle M Greenawalt; Mingli Yang; Timothy J Yeatman
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

10.  Investigating bacterial sources of toxicity as an environmental contributor to dopaminergic neurodegeneration.

Authors:  Kim A Caldwell; Michelle L Tucci; Jafa Armagost; Tyler W Hodges; Jue Chen; Shermeen B Memon; Jeana E Blalock; Susan M DeLeon; Robert H Findlay; Qingmin Ruan; Philip J Webber; David G Standaert; Julie B Olson; Guy A Caldwell
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

View more
  8 in total

1.  MACF1 Mutations Encoding Highly Conserved Zinc-Binding Residues of the GAR Domain Cause Defects in Neuronal Migration and Axon Guidance.

Authors:  William B Dobyns; Kimberly A Aldinger; Gisele E Ishak; Ghayda M Mirzaa; Andrew E Timms; Megan E Grout; Marjolein H G Dremmen; Rachel Schot; Laura Vandervore; Marjon A van Slegtenhorst; Martina Wilke; Esmee Kasteleijn; Arthur S Lee; Brenda J Barry; Katherine R Chao; Krzysztof Szczałuba; Joyce Kobori; Andrea Hanson-Kahn; Jonathan A Bernstein; Lucinda Carr; Felice D'Arco; Kaori Miyana; Tetsuya Okazaki; Yoshiaki Saito; Masayuki Sasaki; Soma Das; Marsha M Wheeler; Michael J Bamshad; Deborah A Nickerson; Elizabeth C Engle; Frans W Verheijen; Dan Doherty; Grazia M S Mancini
Journal:  Am J Hum Genet       Date:  2018-11-21       Impact factor: 11.025

Review 2.  The role of MACF1 in nervous system development and maintenance.

Authors:  Jeffrey J Moffat; Minhan Ka; Eui-Man Jung; Amanda L Smith; Woo-Yang Kim
Journal:  Semin Cell Dev Biol       Date:  2017-06-01       Impact factor: 7.727

3.  Forward Genetic Screen in Caenorhabditis elegans Suggests F57A10.2 and acp-4 As Suppressors of C9ORF72 Related Phenotypes.

Authors:  Xin Wang; Limin Hao; Taixiang Saur; Katelyn Joyal; Ying Zhao; Desheng Zhai; Jie Li; Mochtar Pribadi; Giovanni Coppola; Bruce M Cohen; Edgar A Buttner
Journal:  Front Mol Neurosci       Date:  2016-11-08       Impact factor: 5.639

4.  Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference.

Authors:  Qing-Rong Liu; Ana Canseco-Alba; Hai-Ying Zhang; Patricia Tagliaferro; Monika Chung; Eugene Dennis; Branden Sanabria; Norman Schanz; Joao Carlos Escosteguy-Neto; Hiroki Ishiguro; Zhicheng Lin; Susan Sgro; Claire M Leonard; Jair Guilherme Santos-Junior; Eliot L Gardner; Josephine M Egan; Jeung Woon Lee; Zheng-Xiong Xi; Emmanuel S Onaivi
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

Review 5.  Strength Through Unity: The Power of the Mega-Scaffold MACF1.

Authors:  Rebecca Cusseddu; Amélie Robert; Jean-François Côté
Journal:  Front Cell Dev Biol       Date:  2021-03-18

Review 6.  Microtubule-Actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets.

Authors:  Quincy A Quick
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

7.  Mesenchymal MACF1 Facilitates SMAD7 Nuclear Translocation to Drive Bone Formation.

Authors:  Fan Zhao; Xiaoli Ma; Wuxia Qiu; Pai Wang; Ru Zhang; Zhihao Chen; Peihong Su; Yan Zhang; Dijie Li; Jianhua Ma; Chaofei Yang; Lei Chen; Chong Yin; Ye Tian; Lifang Hu; Yu Li; Ge Zhang; Xiaoyang Wu; Airong Qian
Journal:  Cells       Date:  2020-03-04       Impact factor: 6.600

8.  Explorative Combined Lipid and Transcriptomic Profiling of Substantia Nigra and Putamen in Parkinson's Disease.

Authors:  Helena Xicoy; Jos F Brouwers; Bé Wieringa; Gerard J M Martens
Journal:  Cells       Date:  2020-08-26       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.